RetinaLyze is an automated eye screening algorithm
RetinaLyze is based on the vision to prevent loss of eyesight. Worldwide diabetes is an increasing problem and +300 million registered diabetics (type 1 or 2) are expected in 2020. Furthermore, +250 million unregistered diabetics are expected by 2020.
One of the most feared consequences of diabetes is retinal diabetic pathology, since this can lead to blindness. Early diagnosis is crucial – and possible with RetinaLyze.
The RetinaLyze system combines the best of the telemedicine and algorithm worlds into a service, which can help you perform screenings for DR and AMD in an easy, fast and efficient manner.